Skip to main content
Top
Published in: European Radiology 8/2018

01-08-2018 | Editorial Comment

CT and MRI of pancreatic cancer: there is no rose without a thorn!

Author: N. Kartalis

Published in: European Radiology | Issue 8/2018

Login to get access

Excerpt

Pancreatic cancer (PC) has a very dismal prognosis, with an overall 5-year patient survival rate of 8% [1]. The only chance for cure is complete surgical tumour removal combined with neo- and/or adjuvant chemotherapy-based regimens. However, at diagnosis, only 15–20% of patients are surgical candidates, whereas approximately half of patients have distant metastases [1]. Furthermore, the probability of metastatic disease at diagnosis is 28% for 1 cm tumours and 94% for those of 3 cm [2]. Among the sites of distant metastatic disease, the liver is the most common. …
Literature
2.
go back to reference Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F (2012) Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148:362–375CrossRefPubMedPubMedCentral Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F (2012) Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 148:362–375CrossRefPubMedPubMedCentral
3.
go back to reference Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15:1028–1061CrossRefPubMed Tempero MA, Malafa MP, Al-Hawary M et al (2017) Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 15:1028–1061CrossRefPubMed
4.
go back to reference Tachezy M, Gebauer F, Janot M et al (2016) Synchronous resections of hepatic oligometastatic pancreatic cancer: disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis. Surgery 160:136–144CrossRefPubMed Tachezy M, Gebauer F, Janot M et al (2016) Synchronous resections of hepatic oligometastatic pancreatic cancer: disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis. Surgery 160:136–144CrossRefPubMed
5.
go back to reference Vilgrain V, Esvan M, Ronot M, Caumont-Prim A, Aubé C, Chatellier G (2016) A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol 26:4595–4615CrossRefPubMed Vilgrain V, Esvan M, Ronot M, Caumont-Prim A, Aubé C, Chatellier G (2016) A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases. Eur Radiol 26:4595–4615CrossRefPubMed
7.
go back to reference Motosugi U, Ichikawa T, Morisaka H et al (2011) Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 260:446–453CrossRefPubMed Motosugi U, Ichikawa T, Morisaka H et al (2011) Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging: comparison with contrast-enhanced multi-detector row CT. Radiology 260:446–453CrossRefPubMed
8.
go back to reference Kim HW, Lee JC, Paik KH et al (2017) Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer. Surgery 161:1579–1587CrossRefPubMed Kim HW, Lee JC, Paik KH et al (2017) Adjunctive role of preoperative liver magnetic resonance imaging for potentially resectable pancreatic cancer. Surgery 161:1579–1587CrossRefPubMed
9.
go back to reference Marion-Audibert AM, Vullierme MP, Ronot M et al (2018) Value of routine MRI with diffusion-weighted-sequences for the detection of liver metastases in patients with potentially resectable pancreatic ductal carcinoma and normal liver CT: a prospective multicenter study. AJR Am J Roentgenol (in press) Marion-Audibert AM, Vullierme MP, Ronot M et al (2018) Value of routine MRI with diffusion-weighted-sequences for the detection of liver metastases in patients with potentially resectable pancreatic ductal carcinoma and normal liver CT: a prospective multicenter study. AJR Am J Roentgenol (in press)
10.
go back to reference Ito T, Sugiura T, Okamura Y et al (2017) The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Pancreatology 17:451–456CrossRefPubMed Ito T, Sugiura T, Okamura Y et al (2017) The diagnostic advantage of EOB-MR imaging over CT in the detection of liver metastasis in patients with potentially resectable pancreatic cancer. Pancreatology 17:451–456CrossRefPubMed
Metadata
Title
CT and MRI of pancreatic cancer: there is no rose without a thorn!
Author
N. Kartalis
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 8/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5486-z

Other articles of this Issue 8/2018

European Radiology 8/2018 Go to the issue